AMKOR TECHNOLOGY, INC. (AMKR) FY2024 Q3 Balance Sheet
As of 2024-09-30
Balance Sheet
As of 2024-09-30
Swipe to see the full flow
Chart details
AMKOR TECHNOLOGY, INC. (AMKR) FY2024 Q3 Balance Sheet
Balance sheet as of 2024-09-30. The chart shows assets, liabilities and equity at that date.
- Assets
- 7,029,086,000 US dollars
- Current assets
- 3,244,318,000 US dollars
- Non-current assets
- 3,784,768,000 US dollars
- Liabilities
- 2,831,832,000 US dollars
- Current liabilities
- 1,572,831,000 US dollars
- Non-current liabilities
- 1,259,001,000 US dollars
- Equity
- 4,197,254,000 US dollars
- Noncontrolling interest
- 33,633,000 US dollars. Included in consolidated equity; this amount is not added again.
- Accounts receivable, net of allowances
- 1,351,817,000 US dollars
- Cash and cash equivalents
- 959,140,000 US dollars
- Short-term investments (amortized cost of $511,944 and $474,663 in 2024 and 2023, respectively)
- 512,333,000 US dollars
- Inventories
- 349,513,000 US dollars
- Other current assets
- 71,515,000 US dollars
- Property, plant and equipment, net
- 3,538,841,000 US dollars
- Operating lease right of use assets
- 114,104,000 US dollars
- Other assets
- 111,394,000 US dollars
- Goodwill
- 19,643,000 US dollars
- Restricted cash
- 786,000 US dollars
- Trade accounts payable
- 811,946,000 US dollars
- Accrued expenses
- 315,260,000 US dollars
- Capital expenditures payable
- 210,398,000 US dollars
- Short-term borrowings and current portion of long-term debt
- 207,570,000 US dollars
- Short-term operating lease liability
- 27,657,000 US dollars
- Long-term debt
- 893,994,000 US dollars
- Other non-current liabilities
- 215,144,000 US dollars
- Pension and severance obligations
- 87,584,000 US dollars
- Long-term operating lease liabilities
- 62,279,000 US dollars
- Retained earnings
- 2,349,938,000 US dollars
- Additional paid-in capital
- 2,028,024,000 US dollars
- Accumulated other comprehensive income (loss)
- 10,248,000 US dollars
- Common stock, $0.001 par value, 500,000 shares authorized; 292,992 and 292,167 shares issued; and 246,630 and 245,888 shares outstanding in 2024 and 2023, respectively
- 293,000 US dollars
- Preferred stock, $0.001 par value, 10,000 shares authorized, designated Series A, none issued
- 0 US dollars
- Non-controlling interests in subsidiaries
- 33,633,000 US dollars
- Treasury stock, at cost, 46,362 and 46,279 shares in 2024 and 2023, respectively
- negative 224,882,000 US dollars
- Gross equity (calculated)
- 4,422,136,000 US dollars. Net equity plus the magnitudes of its negative contributions equals gross positive equity. The negative contributions enter this reconciliation as add-backs; their filed signs stay negative.
Chart connections
- Assets equal liabilities plus consolidated equity. Consolidated equity includes noncontrolling interests when reported.
- Treasury shares and other negative equity contributions reduce equity.

Free to share unchanged, with credit to Plicit.ai · CC BY-NC-ND 4.0Download PNG
Product waitlist
Health Check and Teardown for your own company
A health check uncovers insights of your private books, not a public ticker. Join this list to get notified as soon as we go-live!
